Skip to content

Ayahuasca for anxiety: all studies

Page 2 of 8: studies 11 to 20 of 73, newest first. Back to the ayahuasca for anxiety overview

Research

Long-Term Mental Health and Wellbeing Outcomes Associated with Naturalistic Ayahuasca Consumption.

Journal of Psychoactive Drugs February 20, 2025 Broc A. Pagni, Andreas Halman, Jerome Sarris et al. 7 citations

The durability of ayahuasca's effects on mental health and the influence of clinical diagnoses on therapeutic response is unclear. Adults with no prior exposure to ayahuasca (n = 66) participating in neo-shamanic ayahuasca ceremonies completed questionnaires at baseline, 7 days, and 1, 6, and 12 months. Mixed models were used to characterize temporal trajectories in mental health, alcohol and...

Effects of ayahuasca on fear and anxiety: cross-talk between 5HT1A and 5HT2A receptors

Psychedelics December 10, 2024 Lorena Terene Lopes Guerra, Rafael G. Dos Santos, Jaime E. C. Hallak 3 citations

Ayahuasca is a hallucinogenic substance currently being investigated for the treatment of mood, anxiety, and trauma-related disorders. Evidence from animal and human studies suggest that the effects of ayahuasca involve modulation of neural substrates relevant for emotional processing, especially in regions rich in serotonergic receptors. Moreover, preclinical studies also show that ayahuasca...

Ayahuasca, etnofarmacologia e usos no tratamento do transtorno de ansiedade: uma revisão sistemática

Brazilian Journal of Health Review December 3, 2024 Francy Gizella Marroquin Rincon, Rhaiana de Fatima Vidal Gondim, Josana de Castro Peixoto

A ansiedade tem sido um dos principais probelmas de saúde mental na atualidade. Os transtornos de ansiedade afetam milhões de pessoas e que os tratamentos convencionais apresentam limitações, como efeitos colaterais e potenciais de dependência, este estudo busca explorar o potencial terapêutico da ayahuasca no tratamento de transtornos de ansiedade. O objetivo do estudo foi analisar e discutir...

Psychedelics: A review of their effects on recalled aversive memories and fear/anxiety expression in rodents

Neuroscience & Biobehavioral Reviews September 20, 2024 Isabel Werle, Leandro J Bertoglio 17 citations

Threatening events and stressful experiences can lead to maladaptive memories and related behaviors. Existing treatments often fail to address these issues linked to anxiety/stress-related disorders effectively. This review identifies dose ranges associated with specific actions across various psychedelics. We examined psilocybin/psilocin, lysergic acid diethylamide (LSD),...

Embracing Change: Impermanence Acceptance Mediates Differences in Death Processing Between Ayahuasca Users and Non-users

July 28, 2024 Jonathan David, Aviva Berkovich-Ohana, Yair Dor-Ziderman 2 citations preprint

Background: How the human psyche interacts with the theme of death is fundamental to individual and societal life, profoundly influencing cognition, affect, and behavior. Death-related psychological phenomena, such as death anxiety and acceptance, have been shown in clinical studies to be influenced by psychedelic (LSD and psilocybin) interventions. However, the literature lacks a comprehensive...

IS PSYCHEDELIC TREATMENT OF MENTAL HEALTH DISORDERS READY FOR PRIME TIME?

Journal of Pakistan Psychiatric Society June 30, 2024 Nauman Ashraf 1 citation

Psychedelics, substances known to alter perception, mood, and consciousness, have been used across various cultures for centuries, often in religious ceremonies to facilitate spiritual experiences. Lysergic acid diethylamide (LSD) was used clinically from the 1950s until its ban in 1967. Recently, there has been a resurgence of interest in psychedelics for treating mental health disorders such...

Rapid and prolonged antidepressant and antianxiety effects of psilocybin, lysergic acid diethylamide, ayahuasca, and 3, 4-methylenedioxy-methamphetamine. A systematic review and meta-analysis of randomized controlled trials

medRxiv June 20, 2024 Dimy Fluyau, Vasanth Kattalai Kailasam, Neelambika Revadigar preprint

Abstract Background Hallucinogens attract research as alternatives to the commonly used medications to treat major depressive and anxiety disorders. Aims Assess hallucinogens’ efficacy for managing depressive and anxiety symptoms and evaluate their safety profiles. Method In five databases, we searched for randomized controlled trials of hallucinogens targeting depressive and anxiety symptoms....

DOI: 10.1101/2024.06.17.24308787 (opens in new tab) Full text (opens in new tab) Methamphetamine Antidepressant Meta-analysis Methylenedioxy +1

"Vine of the Soul": The Potential of Ayahuasca for Reducing Depression, Anxiety, and Stress among Ceremony Participants and the Role of Rumination

May 1, 2024 Banan Ramarushton

Rumination is a well-established risk factor for the onset and maintenance of depression and anxiety and has been identified as a transdiagnostic factor due to its association with multiple forms of psychopathology. A renaissance of psychedelic research shows promise in treating psychopathology with potential for acting on ruminative processes. Despite the growing interest and developments in...

Emotion regulation effects of Ayahuasca in experienced subjects during implicit aversive stimulation: An fMRI study.

Journal of Ethnopharmacology February 10, 2024 Tiago Arruda Sanchez, Lucas Rego Ramos, Felipe Araujo et al. 12 citations

Ayahuasca is a beverage used in Amazonian traditional medicine and it has been part of the human experience for millennia as well as other different psychoactive plants. Although Ayahuasca has been proposed as potentially therapeutic as an anxiolytic and antidepressant, whilst no studies have been carried out so far investigating their direct effect on brain emotional processing. This study...

Subjective Effects of a Single Dose of Ayahuasca among College Students with Harmful Alcohol Use: Qualitative Analysis of Participant Accounts

Psychoactives November 17, 2023 Anna Beatriz Vicentini, Lucas Silva Rodrigues, Giordano Novak Rossi et al. 4 citations

Alcohol is the recreational drug most frequently consumed, and its high frequency of use can lead to worsening social, psychological, and domestic issues. The age group most susceptible to alcohol dependence is 18- to 24-year-old youths, demanding interventional tools to target early involvement risks. Ayahuasca seems to be a promising therapeutic tool since evidence suggests it presents...